Upgrade to SI Premium - Free Trial

FIGS Releases First Quarter 2023 Financial Results

May 4, 2023 4:05 PM

Net Revenues Growth of 9.2% YoY, Net Income of $1.9 million, Net Income Margin of 1.6% and Adjusted EBITDA Margin of 13.4%

SANTA MONICA, Calif.--(BUSINESS WIRE)-- FIGS, Inc. (NYSE: FIGS) (the “Company”), the direct-to-consumer apparel and lifestyle brand dedicated to the healthcare community, today released its first quarter 2023 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.

“Our first quarter performance was better than expected and reflects progress against our key initiatives,” said Trina Spear, Chief Executive Officer and Co-Founder, “We remain intently focused on product innovation and connecting deeply with our healthcare community. FIGS is an iconic brand and we look forward to advancing our leadership position within the healthcare apparel industry, while driving profitable growth for the long term.”

First Quarter 2023 Financial Highlights

Key Operating Metrics

Financial Outlook

For Full-Year 2023, the Company now expects:

Net Revenues Growth as Compared to 2022

5.5% to 7.5%

Adjusted EBITDA Margin(1)(4)

12% to 13%

Daniella Turenshine, Chief Financial Officer, commented, “We are pleased with our financial results and believe that we are well positioned to drive accelerated growth once macro headwinds subside. We have a strong balance sheet and the ability to generate healthy free cash flow that we believe will enable us to effectively manage near term macro challenges while continuing to invest in our future growth.”

(1)

“Net income margin” and “adjusted EBITDA margin” are calculated by dividing net income and adjusted EBITDA by net revenues, respectively.

(2)

“Net income, as adjusted,” “diluted earnings per share, as adjusted,” “adjusted EBITDA” and “adjusted EBITDA margin” are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Reconciliations of GAAP to Non-GAAP Measures” below for more information regarding the Company’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

(3)

“Active customers,” “net revenues per active customer” and “average order value” are key operational and business metrics that are important to understanding the Company’s performance. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Key Operating Metrics” below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.

(4)

The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. For more information regarding the Company’s use of non-GAAP financial measures, please see the section titled “Non-GAAP Financial Measures and Key Operating Metrics.”

Conference Call Details

FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company’s financial and business results and outlook. To participate, please dial 1-833-470-1428 (US) or 1-404-975-4839 (International) and the conference ID 493313. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on May 11, 2023. To access the replay, please dial 1-866-813-9403 (US) or +44-204-525-0658 (International) and the conference ID 103434. An archive of the webcast will be available on FIGS’ investor relations website at ir.wearfigs.com.

Non-GAAP Financial Measures and Key Operating Metrics

In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K.

The Company uses “net income, as adjusted,” “diluted earnings per share, as adjusted,” “adjusted EBITDA” and “adjusted EBITDA margin” to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company calculates “net income, as adjusted,” as net income adjusted to exclude transaction costs, expenses related to non-ordinary course disputes, other than temporary impairment of held-to-maturity investments, stock-based compensation, including expense related to award modifications, accelerated performance awards and ambassador grants in connection with its initial public offering, and expense resulting from the retirement of the Company’s previous CFO, and the income tax impact of these adjustments. The Company calculates “diluted earnings per share, as adjusted” as net income, as adjusted divided by diluted shares outstanding. The Company calculates “adjusted EBITDA” as net income adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates “adjusted EBITDA margin” by dividing adjusted EBITDA by net revenues.

Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading “Reconciliations of GAAP to Non-GAAP Measures.”

The Company has also included herein “active customers,” “net revenues per active customer” and “average order value,” which are key operational and business metrics that are important to understanding Company performance. The number of active customers is an important indicator of growth as it reflects the reach of the Company’s digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes the relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories and price points as well as expand internationally, average order value may fluctuate.

Active customers as of March 31, 2023 and 2022, respectively, net revenues per active customer as of March 31, 2023 and 2022, respectively, and average order value for the three months ended March 31, 2023 and 2022, respectively, are presented below under the heading “Key Operating Metrics.”

About FIGS

FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products for healthcare professionals that feature an unmatched combination of comfort, durability, function, and style. We market and sell our products in 14 countries directly through our digital platform to provide a seamless experience for healthcare professionals.

Forward Looking Statements

This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words “anticipate”, “believe”, “contemplate”, “continue”, “could”, “estimate”, “expect”, “forecast”, “future”, “intend”, “may”, “might”, “opportunity”, “outlook”, “plan”, “possible”, “potential”, “predict”, “project,” “should”, “strategy”, “strive”, “target”, “will” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company’s focus on product innovation and connecting deeply with its community; the Company’s plans for advancing its leadership position within the healthcare apparel industry while driving profitable growth for the long term; the Company’s belief that it is well positioned to drive accelerated growth once macro headwinds subside; the Company’s belief that its strong balance sheet and ability to generate healthy free cash flow enable it to effectively manage near term macro challenges while continuing to invest in its future growth and the Company’s outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2023; all of which reflect the Company’s expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, our actual results performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the impact of COVID-19 and macroeconomic trends on the Company’s operations; the Company’s ability to maintain its recent rapid growth and effectively manage its growth; the Company’s ability to maintain profitability; the Company’s ability to maintain the value and reputation of its brand; the Company’s ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company’s marketing efforts; the Company’s ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company’s marketing efforts or use of social media; the Company’s ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company’s ability to maintain its key employees; the Company’s ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company’s shipping arrangements; the successful operation of the Company’s distribution and warehouse management systems; the Company’s ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company’s products; the Company’s reliance on a limited number of third-party suppliers; the fluctuating costs of raw materials; the Company’s failure to protect its intellectual property rights; the fact that the operations of many of the Company’s suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties, and factors discussed in the “Risk Factors” section of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 to be filed with the Securities and Exchange Commission (“SEC”), the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 28, 2023, and the Company’s other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

FIGS, INC.

BALANCE SHEETS
(In thousands, except share and per share data)

As of

March 31,
2023

December 31,
2022

Assets

(Unaudited)

Current assets

Cash and cash equivalents

$

155,877

$

159,775

Accounts receivable

3,781

6,866

Inventory, net

180,373

177,976

Prepaid expenses and other current assets

9,580

11,883

Total current assets

349,611

356,500

Non-current assets

Property and equipment, net

11,241

11,024

Operating lease right-of-use assets

14,646

15,312

Deferred tax assets

11,411

10,971

Other assets

1,195

1,257

Total non-current assets

38,493

38,564

Total assets

$

388,104

$

395,064

Liabilities and stockholders’ equity

Current liabilities

Accounts payable

$

8,571

$

20,906

Operating lease liabilities

3,437

3,408

Accrued expenses

21,270

26,164

Accrued compensation and benefits

3,646

3,415

Sales tax payable

3,706

3,374

Gift card liability

7,531

7,882

Deferred revenue

706

2,786

Returns reserve

3,502

3,458

Income tax payable

382

Total current liabilities

52,751

71,393

Non-current liabilities

Operating lease liabilities, non-current

14,984

15,756

Other non-current liabilities

176

176

Total liabilities

$

67,911

$

87,325

Commitments and contingencies

Stockholders’ equity

Class A Common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 159,576,825 and 159,351,307 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively

16

16

Class B Common stock — par value $0.0001 per share, 150,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 7,482,014 and 7,210,795 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively

Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of March 31, 2023 and December 31, 2022; zero shares issued and outstanding as of March 31, 2023 and December 31, 2022

Additional paid-in capital

279,151

268,606

Retained earnings

41,026

39,117

Total stockholders’ equity

320,193

307,739

Total liabilities and stockholders’ equity

$

388,104

$

395,064

FIGS, INC.

STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(In thousands, except share and per share data)
(Unaudited)

Three months ended March 31,

2023

2022

Net revenues

$

120,232

$

110,100

Cost of goods sold

34,556

31,670

Gross profit

85,676

78,430

Operating expenses

Selling

31,158

22,058

Marketing

17,064

15,408

General and administrative

34,157

27,219

Total operating expenses

82,379

64,685

Net income from operations

3,297

13,745

Other income, net

Interest income

1,072

9

Other expense

(1

)

(1

)

Total other income, net

1,071

8

Net income before provision for income taxes

4,368

13,753

Provision for income taxes

2,459

4,854

Net income and comprehensive income

$

1,909

$

8,899

Earnings attributable to Class A and Class B common stockholders

Basic earnings per share

$

0.01

$

0.05

Diluted earnings per share

$

0.01

$

0.05

Weighted-average shares outstanding—basic

166,773,335

164,406,142

Weighted-average shares outstanding—diluted

182,853,746

193,379,275

FIGS, INC.

STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

Three months ended
March 31,

2023

2022

Cash flows from operating activities:

Net income

$

1,909

$

8,899

Adjustments to reconcile net income to net cash used in operating activities:

Depreciation and amortization expense

659

375

Deferred income taxes

(440

)

(406

)

Non-cash operating lease cost

666

374

Stock-based compensation

10,790

8,477

Changes in operating assets and liabilities:

Accounts receivable

3,085

(469

)

Inventory

(2,397

)

(16,697

)

Prepaid expenses and other current assets

2,303

(3,857

)

Other assets

62

(185

)

Accounts payable

(12,439

)

2,372

Accrued expenses

(4,894

)

(560

)

Accrued compensation and benefits

231

(2,371

)

Sales tax payable

332

607

Gift card liability

(351

)

(315

)

Deferred revenue

(2,080

)

9

Returns reserve

44

(233

)

Income tax payable

382

(3,648

)

Operating lease liabilities

(743

)

(389

)

Net cash used in operating activities

(2,881

)

(8,017

)

Cash flows from investing activities:

Purchases of property and equipment

(772

)

(364

)

Net cash used in investing activities

(772

)

(364

)

Cash flows from financing activities:

Proceeds from stock option exercises and employee stock purchases

1

352

Tax payments related to net share settlements on restricted stock units

(246

)

Net cash (used in) provided by financing activities

(245

)

352

Net change in cash, cash equivalents, and restricted cash

(3,898

)

(8,029

)

Cash, cash equivalents, and restricted cash, beginning of period

159,775

197,430

Cash, cash equivalents, end of period

$

155,877

$

189,401

FIGS, INC.

RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES
(Unaudited)

The following table presents a reconciliation of Net income, as adjusted to Net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents Diluted earnings per share (“EPS”), as adjusted and Diluted earnings per share:

Three months ended
March 31,

2023

2022

(in thousands, except share and per share amounts)

Net income

$

1,909

$

8,899

Add (deduct):

Expenses related to non-ordinary course disputes(1)

1,256

2,417

Income tax impacts of items above

(707

)

(853

)

Net income, as adjusted

$

2,458

$

10,463

Diluted EPS

$

0.01

$

0.05

Diluted EPS, as adjusted

$

0.01

$

0.05

Weighted-average shares used to compute Diluted EPS and Diluted EPS, as adjusted

182,853,746

193,379,275

(1)

Exclusively represents attorney’s fees, cost and expenses incurred by the Company in connection with the Company’s litigation against Strategic Partners, Inc., as further described in the section titled “Legal Proceedings” appearing in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

The following table presents a reconciliation of Adjusted EBITDA to Net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents Adjusted EBITDA margin with Net income margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

Three months ended
March 31,

2023

2022

(in thousands, except margin)

Net income

$

1,909

$

8,899

Add (deduct):

Other income, net

(1,071

)

(8

)

Provision for income taxes

2,459

4,854

Depreciation and amortization expense(1)

659

375

Stock-based compensation and related expense(2)

10,865

8,447

Expenses related to non-ordinary course disputes(3)

1,256

2,417

Adjusted EBITDA

$

16,077

$

24,984

Net revenues

$

120,232

$

110,100

Net income margin(4)

1.6

%

8.1

%

Adjusted EBITDA margin

13.4

%

22.7

%

(1)

Excludes amortization of debt issuance costs included in “Other income, net.”

(2)

Includes stock-based compensation expense and payroll taxes related to equity award activity.

(3)

Exclusively represents attorney’s fees, cost and expenses incurred by the Company in connection with the Company’s litigation against Strategic Partners, Inc., as further described in the section titled “Legal Proceedings” appearing in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

(4)

Net income margin represents Net income as a percentage of Net revenues.

FIGS, INC.

KEY OPERATING METRICS
(Unaudited)

Active customers as of March 31, 2023 and 2022, respectively, net revenues per active customer as of March 31, 2023 and 2022, respectively, and average order value for the three months ended March 31, 2023 and 2022, respectively, are presented in the following tables:

As of March 31,

2023

2022

(in thousands)

Active customers

2,390

1,962

As of March 31,

2023

2022

Net revenues per active customer

$

216

$

226

Three months ended
March 31,

2023

2022

Average order value

$

114

$

116

Investors:

Jean Fontana

[email protected]



Media:

Todd Maron

[email protected]

Source: FIGS, Inc.

Categories

Business Wire Press Releases

Next Articles